12:00 AM
 | 
Nov 12, 2012
 |  BC Week In Review  |  Company News  |  Deals

Chiromics, Bristol-Myers, GlaxoSmithKline deal

Chiromics announced separate deals with the pharmas to discover small molecules against undisclosed targets. Bristol-Myers will receive a non-exclusive license to Chiromics' chemical compound library and an exclusive license...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >